[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100333068":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":11,"centralContacts":15,"locations":24,"responsibleParty":42,"collaborators":7,"id":45,"slug":7,"hasResults":46,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":7,"eligibilityCriteria":50,"healthyVolunteers":46,"sex":51,"minAge":52,"maxAge":7,"enrollmentInfo":53,"targetDuration":7,"studyType":56,"phases":7,"briefSummary":57,"conditions":58,"keywords":60,"overallStatus":27,"whyStopped":7,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":74},{"fullName":5,"class":6},"Indiana University","OTHER",null,[9],{"type":6,"name":10,"description":10,"armGroupLabels":7,"otherNames":7},"This is a non-interventional trial",[12],{"name":13,"affiliation":5,"role":14},"Attaya Suvannasankha, MD","PRINCIPAL_INVESTIGATOR",[16,20],{"name":13,"role":17,"phone":18,"phoneExt":7,"email":19},"CONTACT","317-274-0843","asuvanna@iu.edu",{"name":21,"role":17,"phone":22,"phoneExt":7,"email":23},"Nisha George, MD","(317) 274-6635","nishgeor@iu.edu",[25],{"facility":26,"status":27,"city":28,"state":29,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"Indiana University Simon Cancer Center","RECRUITING","Indianapolis","Indiana","46202","United States","US",{"type":34,"coordinates":35},"Point",[36,37],-86.15804,39.76838,{"lat":37,"lon":36},[40,41],{"name":13,"role":17,"phone":18,"phoneExt":7,"email":19},{"name":21,"role":17,"phone":22,"phoneExt":7,"email":23},{"type":14,"investigatorFullName":43,"investigatorTitle":44,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Attaya Suvannasankha","Clinical Professor of Clinical Medicine","100333068",false,"NCT03616483","The Indiana Myeloma Registry","Collection of Specimens and Clinical Data to Create A Bio-repository for the Multiple Myeloma Program: The Indiana Myeloma Registry","Inclusion Criteria:\n\n1. Male or female patients ≥ 18 years of age at the time of informed consent\n2. Has been diagnosed with or is suspected to have one of the following:\n\n   1. Monoclonal Gammopathy of Undetermined Significance (MGUS)\n   2. Smoldering Multiple Myeloma\n   3. Multiple Myeloma\n   4. Bony or Soft Tissue Plasmacytoma\n   5. Primary Amyloidosis\n\nExclusion Criteria:\n\n\\\u003C 18 years of age\n\nHave not been diagnosed with one of the following:\n\nMonoclonal Gammopathy of Undetermined Significance (MGUS) b.Smoldering Multiple Myeloma c.Multiple Myeloma d.Bony or Soft Tissue Plasmacytoma e.Primary Amyloidosis","ALL","18 Years",{"count":54,"type":55},2500,"ESTIMATED","OBSERVATIONAL","This is a prospective, non-interventional, observational study. The purpose of this study is to collect data and bio-specimens that will support future research",[59],"Plasma Cell Dyscrasias",[61,62,63,64],"Multiple myeloma","Monoclonal gammopathy of undetermined significance","Plasmacytoma","Smoldering multiple myeloma","2025-11-06",{"date":67,"type":68},"2025-11-10","ACTUAL",{"date":70,"type":68},"2018-06-18",{"date":72,"type":55},"2028-06-30",{"name":5,"class":6},1]